Attil12

T-cell membrane-anchored tumor-targeted interleukin-12 · M.D. Anderson Cancer Center

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Attil12, covering 2025-10-20 to 2025-10-20. Get the full timeline:

Most recent: Clinical Trial Update: A First-In-Human Phase 1 Trial of T-Cell Membrane-Anchored Tumor Targeted Il12 (Attil12)- T-Cell Therapy in Subjects With Advanced/Metastatic Soft Tissue and Bone Sarcoma [Phase 1]

See pricing